22 results about "Dialysis Therapy" patented technology

A water treatment plant or system for the production of permeate includes a reverse osmosis stage and a permeate stage. The reverse osmosis stage can include a piping system having a supply line for process input water, a reverse osmosis pump, and a reverse osmosis tank. The reverse osmosis tank has an inlet for process input water coming from the reverse osmosis pump, a membrane, and an outlet for permeate. The permeate stage, which can have a line system forming a circuit, can include a permeate tank, a permeate pump, and a tapping point for connecting at least one consumer or user of permeate. The reverse osmosis stage and the permeate stage can be connected to one another via a connecting line in such a way that the reverse osmosis stage feeds the permeate stage with permeate. The circuit of the permeate stage can include a sterile filter.

Systems, devices and / or methods include receiving, by at least one processor, current sorbent material module recharge characteristics associated with a sorbent material module recharge of a sorbent material module configured for dialysis therapy of a patient. The at least one processor may input the current sorbent material module recharge characteristics into a recharge machine learning model to output a recharge completion estimation of the sorbent material module based at least in part on recharge machine learning model parameters, wherein the recharge completion estimation represents a degree of sorbent material module recharge being complete. The at least one processor may control a sorbent material module recharge pump to vary the current sorbent material module recharge characteristics based at least in part on the recharge completion estimation.

Main requirement: Water treatment plant for the production of permeate, especially for dialysis therapy, comprising • a reverse osmosis stage (137) with a piping system comprising a supply line (131) for process inlet water (100), a reverse osmosis pump (103) and a reverse osmosis tank (130), wherein the reverse osmosis tank (130) has an inlet (143) for the process inlet water (100) coming from the reverse osmosis pump (103), a membrane (104) and an outlet (144) for permeate (108), • a permeate stage (139) with a circulating piping system comprising a permeate tank (112), a permeate pump (114) and a take-off point (134) for connecting at least one consumer or user of permeate (108), wherein the reverse osmosis stage (137) and the permeate stage (139) are connected to each other via a connecting line (138) such that the reverse osmosis stage (137) feeds the permeate stage (139) with permeate (108), and wherein the circuit of the permeate stage (138) comprises a sterile filter (116).

Dialysis systems and methods are described which can include a number of features. The dialysis systems described can be to provide dialysis therapy to a patient in the comfort of their own home. The dialysis system can be configured to prepare purified water from a tap water source in real-time that is used for creating a dialysate solution. The dialysis systems described also include features that make it easy for a patient to self-administer therapy. For example, the dialysis systems include disposable cartridge and patient tubing sets that are easily installed on the dialysis system and automatically align the tubing set, sensors, venous drip chamber, and other features with the corresponding components on the dialysis system. Methods of use are also provided, including automated priming sequences, blood return sequences, and dynamic balancing methods for controlling a rate of fluid transfer during different types of dialysis, including hemodialysis, ultrafiltration, and hemodiafiltration.

A renal failure blood therapy system includes a memory device storing a therapy target for a patient. The system also includes a processor configured to receive the therapy target for the patient, receive a desired solute concentration for the patient, and apply the therapy target and the desired solute concentration as inputs to an optimization routine. The processor is also configured to execute the optimization routine to determine at least one dialysis therapy prescription specifying at least a dialysis therapy duration, a dialysis therapy frequency, and at least one of a dialysis therapy blood flow rate or a dialysis therapy dialysate flow rate. The processor is further configured to display the at least one dialysis therapy prescription for confirmation or selection by a clinician and transmit the selected or confirmed dialysis therapy prescription to a dialysis machine for a subsequent dialysis treatment for the patient.

A mobile dialysis therapy cart includes a top shelf and a fluid bag management compartment located beneath the top shelf. The fluid bag management compartment includes at least one heating device for heating a fluid bag. The mobile dialysis therapy cart also includes at least one temperature sensor located to sense a temperature associated with dialysis fluid located within the fluid bag. The mobile dialysis therapy cart further includes a control unit communicatively coupled to the at least one heating device and the at least one temperature sensor. The control unit is programmed to use an output from the at least one temperature sensor to operate the at least one heating device to heat the dialysis fluid within the fluid bag to a desired temperature.

A system is configured to provide treatment fluid for use in dialysis therapy. A first sub-system (30) provides a flow of product water in a circulation path (34). A second sub-system (10) is fluidly connected to the circulation path on first and second connecting paths (CP1, CP2) and is operable to generate treatment fluid by use of product water. In a disinfection mode of the system, the second sub-system obtains product water on the first or second connecting path, produces a disinfection fluid based on the product water, and performs a disinfection of at least part of the second sub-system by use of the disinfection fluid. As part of the disinfection mode, the second sub-system generates a throughflow of disinfection fluid in the first and second connecting paths and in the circulation path between the first and second connecting paths, allowing the second sub-system to be disinfected separately from the first sub-system.

An arrangement is provided for supplying a fluid for use in dialysis therapy. The arrangement comprises a vessel (10) for holding the fluid, an inlet line (L1) for directing the fluid to an inlet port (10a) on the vessel, an electrical heating device (12) for heating the fluid in the vessel, and a supply line (L2) for directing the fluid from an outlet port (10b) of the vessel. A fluid pump (P1) is arranged to achieve a flow of the fluid along the inlet line, through the vessel, and along the supply line. A heat exchanger (14) is arranged to transfer heat between the inlet line and the supply line, and a heat pump (15), for example thermoelectric, is operable to transfer heat between the inlet line and the supply line. A control device (30) operates the heat pump so as to achieve a target temperature of the fluid in the supply line, downstream of the heat exchanger and the second location.

Systems, components, and methods are provided for a flexible, efficient system capable of producing customized dialysis fluid at the point of care. By enabling precise control over the solution's composition, the system significantly the customization, safety, and effectiveness of dialysis therapy. The placement of sensors and feedback mechanisms ensures accurate monitoring and adjustment of the solution's composition for dialysis fluid for patient treatment.

Main claim: Water treatment plant for the production of permeate, in particular for dialysis therapy, comprising: • a reverse osmosis stage (137) with a piping system comprising a supply line (131) for process inlet water (100), a reverse osmosis pump (103) and a reverse osmosis tank (130), wherein the reverse osmosis tank (130) has an inlet (143) for the process inlet water (100) coming from the reverse osmosis pump (103), a membrane (104) and an outlet (144) for permeate (108), • a permeate stage (139) with a circulating piping system comprising a permeate tank (112), a permeate pump (114) and a discharge point (134) for connecting at least one consumer or user of permeate (108), wherein the reverse osmosis stage (137) and the permeate stage (139) are connected to each other via a connecting line (138) such that the reverse osmosis stage (137) feeds the permeate stage (139) with permeate (108),and wherein the permeate stage circuit (138) includes a sterile filter (116).

An apparatus is provided for handling waste fluid, WF, generated in connection with dialysis therapy, to mitigate the risk that a patient undergoing dialysis therapy is exposed to harmful leakage currents. The apparatus includes a fluid disposal arrangement, FDA (40), which is configured to receive WF and define a fluid flow path (41) for directing WF to a drain. The FDA (40) is operable to combine WF with a dilution fluid, DF, at a supply region (44) in the fluid flow path (41). A control arrangement (50) is configured to operate one or more flow controllers (42, 45) in the FDA (40) to relatively control a first fluid flow of DF and a second fluid flow of WF into the supply region (44) so that a hypothetical homogeneous mixture of DF and WF at the supply region (44) has an electrical conductivity below a first limit value.

Dialysis systems and methods are described which can include a number of features. The dialysis systems described can be to provide dialysis therapy to a patient in the comfort of their own home. The dialysis system can be configured to prepare purified water from a tap water source in real-time that is used for creating a dialysate solution. The dialysis systems described also include features that make it easy for a patient to self-administer therapy.

Dialysis systems and methods are described which can include a number of features. The dialysis systems described can be to provide dialysis therapy to a patient in the comfort of their own home. The dialysis system can be configured to prepare purified water from a tap water source in real-time that is used for creating a dialysate solution. The dialysis systems described also include features that make it easy for a patient to self-administer therapy.

The present disclosure relates to systems that use adsorption devices or adsorption devices configured for dialysis therapy, such as extracorporeal blood therapy or peritoneal dialysis therapy.

A medical fluid control port assembly is disclosed. The medical fluid control port assembly eliminates contamination of a fluid path in peritoneal dialysis solution containers by incorporating ways to operate fluid flow without using a frangible. The disclosed fluid control port assembly is made up of an upper stem and a lower stem. The upper stem has a male threaded portion configured for mating to the lower stem having a female threaded portion. The upper stem has at least two snapfit ridges and the lower stem has at least one snapfit ridge. The snapfit ridges are provided to lock the fluid control port in a closed configuration to restrict fluid flow, or in an open configuration to initiate fluid flow. The control port is configured to allow a patient to use their fingers to rotate the upper stem and lower stem during dialysis therapy to easily control fluid flow.

Systems, components, and methods are provided for a flexible, efficient system capable of producing customized dialysis fluid at the point of care. By enabling precise control over the solution's composition, the system significantly the customization, safety, and effectiveness of dialysis therapy. The placement of sensors and feedback mechanisms ensures accurate monitoring and adjustment of the solution's composition for dialysis fluid for patient treatment.

The present disclosure relates to a system and a method for determining the dry weight of a patient after dialysis therapy, wherein the patient's blood volume is monitored and blood volume values are output. The blood volume values are recorded and evaluated for a predetermined period of time after reaching an ultrafiltration volume appropriately predetermined for the patient, wherein the dry weight of the patient then is determined on the basis of the rate of change of the blood volume during the predetermined period of time.

A system is configured to generate treatment fluid for use in dialysis by mixing water with one or more liquid concentrates (Cx). The system comprises a fluid path arrangement (L), an input port arrangement in fluid communication with the fluid path arrangement, and a heater (9). The input port arrangement is configured for releasable connection to a set of containers (7) holding the one or more liquid concentrates. The system is operated to perform time-separated sessions of generating treatment fluid. The system is further operated, between the sessions and by use of the heater (9), to perform a first heat disinfection of the fluid path arrangement except for a subset thereof. The system is further operated to arrange at least one of the one or more liquid concentrates in the subset between the time-separated sessions.

An apparatus (100) for use in dialysis therapy, said apparatus comprising: a fluid handling unit (110) configured to interact with fluid communicating between a first fluid interface (131) and a second fluid interface (132); 5 power circuitry (120) connected to the fluid handling unit, said power circuitry including: a primary power inlet (121) connected via a primary circuit to the fluid handling unit; a secondary power inlet (122) connected via a secondary circuit to the fluid 0 handling unit; and a relay circuit (123) configured to disconnect the primary circuit based on voltage being received in the secondary power inlet.

A control device performs a method for power management in relation to a dialysis system installed in a residential space. In the method, the dialysis system is operated to perform a heat disinfection procedure, HDP, in preparation of dialysis therapy. During the HDP, power measurement data representing a momentary power consumption in the residential space is obtained (203). A projected power consumption in the residential space at one or more future time points is determined based on the power measurement data (204). The projected power consumption is evaluated in relation to a maximum limit of power consumption in the residential space, for detection of an upcoming power shortage (205). To counteract the upcoming power shortage, the HDP and / or an operation of at least one electrical device other that the dialysis system in the residential space is modified (206).

A system for performing dialysis therapy includes a first conduit, an inlet sensor configured to sense a first property of a fluid, a flow cell device configured to oxidize the fluid, a second conduit, and an outlet sensor configure to sense a second property of the fluid. The sensed first property and second property can be used to determine a total organic carbon of the fluid. The flow cell device includes a housing including a fluid inlet configured to receive the fluid, a fluid outlet configured to output the fluid, a first chamber fluidly connected to the fluid inlet and outlet, and an energy source that outputs energy to the fluid passing through the first chamber. The flow cell can include a second chamber fluidly separated from and disposed within the first chamber, and the energy source can be disposed within the second chamber.